News

InterMune has posted a net loss of $24.28m for the third quarter 2010, or $0.44 loss per diluted share, compared to net loss of $8.77m, or $0.19 loss

With this take over, Emergent gains access to multiple, advanced stage candidates in the key disease areas of oncology and autoimmunity as well as access to new and

Vangent said that PMITS ensures critical patient-movement equipment is available throughout patient evacuation to save critically injured warfighters’ lives. Military commanders use PMITS to manage and redistribute patient

Abbott Nutrition claims that ZonePerfect Cookie Dough Bars offer antioxidants, vitamins and minerals and protein. The bars are now available in three flavors – Chocolate Chip, Peanut Butter

VRP700 clinical trial is expected to be completed during the first quarter of 2011, depending on patient recruitment and the efficacy of the drug. Verona Pharma said that

Avacta claimed that Optim fills a significant gap in the market by providing detailed analysis using only very small sample volumes, and also enables drug developers to gain

Revenue in markets outside the US increased by 7%, including a 14% increase in Emerging Markets. Revenue in Western Europe was up 3%. Revenue in Established Rest of

Human-cl rhFVIII is a recombinant factor VIII (rFVIII) concentrate developed by Octapharma for the control and prevention of bleeding episodes and for surgical prophylaxis in patients with hemophilia

Methotrexate is an antimetabolite used in the treatment of neoplastic diseases, severe psoriasis, and rheumatoid arthritis, including polyarticular juvenile rheumatoid arthritis. Sandoz is initiating this voluntary recall of